Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies

Hematopoietic CD34+ cells from placental and umbilical cord blood (PUCB) can be valuable vehicles for gene therapy of immunodeficiencies and genetic disorders. We have conducted preclinical studies towards the treatment of HIV-1-infected infants with genetically ‘immunized’ CD34+ cells derived from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Li, Xinqiang (VerfasserIn) , Gervaix, A. (VerfasserIn) , Kang, D. (VerfasserIn) , Law, P. (VerfasserIn) , Spector, S. A. (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Wong-Staal, F. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 07 April 1998
In: Gene therapy
Year: 1998, Jahrgang: 5, Heft: 2, Pages: 233-239
ISSN:1476-5462
DOI:10.1038/sj.gt.3300582
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.gt.3300582
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/3300582
Volltext
Verfasserangaben:X. Li, A. Gervaix, D. Kang, P. Law, S.A. Spector, A.D. Ho, F. Wong-Staal

MARC

LEADER 00000caa a2200000 c 4500
001 1939740533
003 DE-627
005 20251103155523.0
007 cr uuu---uuuuu
008 251030s1998 xx |||||o 00| ||eng c
024 7 |a 10.1038/sj.gt.3300582  |2 doi 
035 |a (DE-627)1939740533 
035 |a (DE-599)KXP1939740533 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Li, Xinqiang  |e VerfasserIn  |0 (DE-588)1380585562  |0 (DE-627)1939890438  |4 aut 
245 1 0 |a Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants  |b preclinical studies  |c X. Li, A. Gervaix, D. Kang, P. Law, S.A. Spector, A.D. Ho, F. Wong-Staal 
246 3 3 |a Gene therapy targeting cord blood-derived CD34 + cells from HIV-exposed infants 
264 1 |c 07 April 1998 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist das Pluszeichen hochgestellt 
500 |a Gesehen am 30.10.2025 
520 |a Hematopoietic CD34+ cells from placental and umbilical cord blood (PUCB) can be valuable vehicles for gene therapy of immunodeficiencies and genetic disorders. We have conducted preclinical studies towards the treatment of HIV-1-infected infants with genetically ‘immunized’ CD34+ cells derived from PUCB using anti-HIV-1 hairpin ribozyme genes. PUCB was collected from 10 newborns of HIV-1-positive mothers. CD34+ cells were enriched with a modified procedure using Dynal immunomagnetic beads and chymopapain, stimulated with stem cell factor (SCF), IL-3 and IL-6, and transduced using cell-free recombinant retroviral vector (MJT) expressing a ribozyme against the U5 region of HIV-1. No significant differences were observed in the growth pattern of CD34+ cells from normal infants, HIV-1 exposed infants or infants confirmed to be infected by HIV-1. The transduction efficiency of the CD34+ cells from all the infants was also comparable. MJT-transduced CD34+ cells from an HIV-1-infected infant were maintained in a liquid culture system for 4 weeks, and the progeny macrophage cells were challenged with the monocyte-tropic laboratory strain, HIV-Bal, or the HIV-1 isolate from the infant’s mother. Significant inhibition of virus replication was observed in ribozyme-transduced cells. Thus, we have demonstrated efficient and stable gene transfer into progenitor cells from the cord blood of HIV-1-exposed or -infected infants and shown that protection from HIV-1 infection was conferred to the progeny cells produced by CD34+ cells transduced with the anti-HIV ribozyme gene construct. 
650 4 |a Biomedicine 
650 4 |a Cell Biology 
650 4 |a Gene Expression 
650 4 |a Gene Therapy 
650 4 |a general 
650 4 |a Human Genetics 
650 4 |a Nanotechnology 
700 1 |a Gervaix, A.  |e VerfasserIn  |4 aut 
700 1 |a Kang, D.  |e VerfasserIn  |4 aut 
700 1 |a Law, P.  |e VerfasserIn  |4 aut 
700 1 |a Spector, S. A.  |e VerfasserIn  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Wong-Staal, F.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Gene therapy  |d London : Nature Publ. Group, 1997  |g 5(1998), 2, Seite 233-239  |h Online-Ressource  |w (DE-627)306583623  |w (DE-600)1497870-2  |w (DE-576)094144656  |x 1476-5462  |7 nnas  |a Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants preclinical studies 
773 1 8 |g volume:5  |g year:1998  |g number:2  |g pages:233-239  |g extent:7  |a Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants preclinical studies 
856 4 0 |u https://doi.org/10.1038/sj.gt.3300582  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/3300582  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251030 
993 |a Article 
994 |a 1998 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 6 
999 |a KXP-PPN1939740533  |e 4794590571 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Im Titel ist das Pluszeichen hochgestellt","Gesehen am 30.10.2025"],"relHost":[{"title":[{"title":"Gene therapy","title_sort":"Gene therapy"}],"language":["eng"],"part":{"issue":"2","pages":"233-239","extent":"7","text":"5(1998), 2, Seite 233-239","year":"1998","volume":"5"},"pubHistory":["Nachgewiesen 4.1997 -"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["306583623"],"zdb":["1497870-2"],"issn":["1476-5462"]},"disp":"Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants preclinical studiesGene therapy","note":["Gesehen am 20.11.18"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"306583623","origin":[{"publisherPlace":"London ; London [u.a.]","dateIssuedKey":"1997","publisher":"Nature Publ. Group ; Macmillan","dateIssuedDisp":"1997-"}]}],"physDesc":[{"extent":"7 S."}],"id":{"eki":["1939740533"],"doi":["10.1038/sj.gt.3300582"]},"recId":"1939740533","origin":[{"dateIssuedDisp":"07 April 1998","dateIssuedKey":"1998"}],"titleAlt":[{"title":"Gene therapy targeting cord blood-derived CD34 + cells from HIV-exposed infants"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"family":"Li","given":"Xinqiang","role":"aut","display":"Li, Xinqiang"},{"role":"aut","given":"A.","display":"Gervaix, A.","family":"Gervaix"},{"display":"Kang, D.","given":"D.","role":"aut","family":"Kang"},{"role":"aut","given":"P.","display":"Law, P.","family":"Law"},{"family":"Spector","given":"S. A.","role":"aut","display":"Spector, S. A."},{"display":"Ho, Anthony Dick","given":"Anthony Dick","role":"aut","family":"Ho"},{"family":"Wong-Staal","given":"F.","role":"aut","display":"Wong-Staal, F."}],"name":{"displayForm":["X. Li, A. Gervaix, D. Kang, P. Law, S.A. Spector, A.D. Ho, F. Wong-Staal"]},"language":["eng"],"title":[{"title_sort":"Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants","subtitle":"preclinical studies","title":"Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants"}]} 
SRT |a LIXINQIANGGENETHERAP0719